Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OCA.NZ Stock Summary
Top 10 Correlated ETFs
OCA.NZ
In the News
OCA.NZ Financial details
Company Rating
Buy
Market Cap
463.46M
Income
59.1M
Revenue
387.12M
Book val./share
1.41
Cash/share
0.01
Dividend
0.01
Dividend %
1.73%
Employees
2.9K
Optionable
No
Shortable
Yes
Earnings
22 May 2024
P/E
34.73
Forward P/E
-
PEG
-58.11
P/S
2.2
P/B
0.56
P/C
61
P/FCF
-9.85
Quick Ratio
0.11
Current Ratio
0.22
Debt / Equity
0.61
LT Debt / Equity
0.61
-
-
EPS (TTM)
0.08
EPS next Y
-
EPS next Q
-
EPS this Y
-74.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-21.75%
Revenue last 5Y
5.74%
Revenue Q/Q
95.03%
EPS Q/Q
100%
-
-
-
-
SMA20
1.61%
SMA50
-11.27%
SMA100
-10%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.02%
Gross Margin
100%
Oper. Margin
14%
Profit Margin
6%
Payout
141%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.55-0.84
52W High
-
52W Low
-
RSI
43.91
Rel Volume
0.14
Avg Volume
1.39M
Volume
192.89K
Perf Week
-7.58%
Perf Month
-3.17%
Perf Quarter
-12.86%
Perf Half Y
-15.28%
-
-
-
-
Beta
0.678
-
-
Volatility
0.02%, 0.02%
Prev Close
1.67%
Price
0.61
Change
1.67%
OCA.NZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-05-31 | 2020-05-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.31 | 0.32 | 0.34 | 0.33 | 0.35 | |
Net income per share | 0.08 | -0.02 | 0.17 | 0.09 | 0.02 | |
Operating cash flow per share | 0.15 | 0.16 | 0.15 | 0.15 | 0.1 | |
Free cash flow per share | 0.03 | 0.1 | 0.1 | 0.07 | 0.02 | |
Cash per share | 0.04 | 0.03 | 0.13 | 0.01 | 0.01 | |
Book value per share | 1.01 | 0.97 | 1.34 | 1.35 | 1.35 | |
Tangible book value per share | 0.99 | 0.96 | 1.32 | 1.33 | 1.34 | |
Share holders equity per share | 1.01 | 0.97 | 1.34 | 1.35 | 1.35 | |
Interest debt per share | 0.45 | 0.63 | 0.55 | 0.62 | 0.86 | |
Market cap | 634.59M | 549.64M | 795.57M | 740.67M | 522.19M | |
Enterprise value | 881.98M | 870.47M | 1.05B | 1.12B | 1.07B | |
P/E ratio | 13.99 | -40.29 | 7.74 | 12.12 | 33.8 | |
Price to sales ratio | 3.39 | 2.84 | 3.78 | 3.2 | 2.11 | |
POCF ratio | 7.1 | 5.53 | 8.29 | 7.02 | 7.44 | |
PFCF ratio | 38.63 | 9.33 | 13.31 | 15.04 | 34.71 | |
P/B Ratio | 1.04 | 0.92 | 0.95 | 0.78 | 0.54 | |
PTB ratio | 1.04 | 0.92 | 0.95 | 0.78 | 0.54 | |
EV to sales | 4.72 | 4.5 | 5.01 | 4.85 | 4.34 | |
Enterprise value over EBITDA | 14.82 | -124.14 | 86.37 | 12.59 | 20.11 | |
EV to operating cash flow | 9.87 | 8.76 | 10.99 | 10.62 | 15.29 | |
EV to free cash flow | 53.69 | 14.77 | 17.64 | 22.77 | 71.32 | |
Earnings yield | 0.07 | -0.02 | 0.13 | 0.08 | 0.03 | |
Free cash flow yield | 0.03 | 0.11 | 0.08 | 0.07 | 0.03 | |
Debt to equity | 0.44 | 0.63 | 0.4 | 0.45 | 0.62 | |
Debt to assets | 0.19 | 0.24 | 0.18 | 0.2 | 0.24 | |
Net debt to EBITDA | 4.16 | -45.75 | 21.21 | 4.27 | 10.32 | |
Current ratio | 0.13 | 0.1 | 0.19 | 0.1 | 0.22 | |
Interest coverage | 16.68 | -4.09 | -0.38 | 7.96 | 2.56 | |
Income quality | 1.97 | -7.28 | 0.93 | 1.73 | 4.54 | |
Dividend Yield | 0.04 | 0.04 | 0.01 | 0.03 | 0.04 | |
Payout ratio | 0.63 | -1.63 | 0.06 | 0.32 | 1.41 | |
Sales general and administrative to revenue | 0.68 | 0.76 | 0 | 0.69 | 0.67 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Capex to operating cash flow | -0.82 | -0.41 | -0.38 | -0.53 | -0.79 | |
Capex to revenue | -0.39 | -0.21 | -0.17 | -0.24 | -0.22 | |
Capex to depreciation | -7.64 | -2.79 | -2.23 | -3.02 | -3.08 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.31 | 0.7 | 2.23 | 1.62 | 0.81 | |
ROIC | 0.08 | -0.01 | 0 | 0.06 | 0.03 | |
Return on tangible assets | 0.03 | -0.01 | 0.06 | 0.03 | 0.01 | |
Graham Net | -1.22 | -1.48 | -1.5 | -1.69 | -2.02 | |
Working capital | -439.79M | -555.78M | -537.27M | -776.01M | -800.25M | |
Tangible asset value | 601.21M | 584.38M | 819.81M | 940.24M | 955.54M | |
Net current asset value | -723.17M | -894.23M | -920.63M | -1.17B | -1.36B | |
Invested capital | 0.44 | 0.63 | 0.4 | 0.45 | 0.62 | |
Average receivables | 36.55M | 41.2M | 42.67M | 55.77M | 86.46M | |
Average payables | 4.95M | 5.99M | 7.58M | 5.67M | 5.92M | |
Average inventory | 0.5 | 1 | 1 | 1 | 53.84M | |
Days sales outstanding | 82.32 | 75.83 | 78.21 | 104.93 | 157.22 | |
Days payables outstanding | 15.44 | 13.3 | 19.7 | 3.87 | 17.8 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 195.85 | |
Receivables turnover | 4.43 | 4.81 | 4.67 | 3.48 | 2.32 | |
Payables turnover | 23.65 | 27.44 | 18.53 | 94.24 | 20.5 | |
Inventory turnover | 144.72M | 160.76M | 172.32M | 192.53M | 1.86 | |
ROE | 0.07 | -0.02 | 0.12 | 0.06 | 0.02 | |
Capex per share | -0.12 | -0.07 | -0.06 | -0.08 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.17 | 0.09 | 0.17 | 0.09 | 0.18 | |
Net income per share | 0.02 | 0 | 0.01 | 0.02 | 0.05 | |
Operating cash flow per share | 0.04 | 0.03 | 0.05 | 0.03 | 0.07 | |
Free cash flow per share | -0.01 | 0.05 | 0.03 | 0.02 | 0.03 | |
Cash per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Book value per share | 1.35 | 1.34 | 1.34 | 1.41 | 1.41 | |
Tangible book value per share | 1.34 | 1.33 | 1.33 | 1.4 | 1.4 | |
Share holders equity per share | 1.35 | 1.34 | 1.34 | 1.41 | 1.41 | |
Interest debt per share | 0.72 | 0.77 | 0.85 | 0.85 | 0.87 | |
Market cap | 648.22M | 545.98M | 526.01M | 556.32M | 512.97M | |
Enterprise value | 1.15B | 1.09B | 1.08B | 1.16B | 1.13B | |
P/E ratio | 14.47 | 64.23 | 30.94 | 7.91 | 3.65 | |
Price to sales ratio | 5.31 | 8.67 | 4.21 | 8.24 | 3.9 | |
POCF ratio | 20.65 | 28.13 | 13.55 | 23.17 | 10.68 | |
PFCF ratio | -145.5 | 13.83 | 28.34 | 46 | 21.21 | |
P/B Ratio | 0.67 | 0.57 | 0.55 | 0.55 | 0.5 | |
PTB ratio | 0.67 | 0.57 | 0.55 | 0.55 | 0.5 | |
EV to sales | 9.42 | 17.34 | 8.61 | 17.24 | 8.55 | |
Enterprise value over EBITDA | 139.28 | 292.57 | 143.65 | 287.46 | 218.64 | |
EV to operating cash flow | 36.65 | 56.26 | 27.75 | 48.46 | 23.44 | |
EV to free cash flow | -258.21 | 27.67 | 58.03 | 96.2 | 46.54 | |
Earnings yield | 0.02 | 0 | 0.01 | 0.03 | 0.07 | |
Free cash flow yield | -0.01 | 0.07 | 0.04 | 0.02 | 0.05 | |
Debt to equity | 0.52 | 0.58 | 0.62 | 0.61 | 0.61 | |
Debt to assets | 0.21 | 0.22 | 0.24 | 0.23 | 0.23 | |
Net debt to EBITDA | 60.79 | 146.28 | 73.49 | 150.01 | 119.01 | |
Current ratio | 0.1 | 0.23 | 0.22 | 0.19 | 0.13 | |
Interest coverage | -0.17 | 0 | -0.14 | 0 | -0.5 | |
Income quality | 2.8 | 9.13 | 9.13 | 1.37 | 1.37 | |
Dividend Yield | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
Payout ratio | 1.12 | 2.18 | 2.18 | 0.19 | 0.19 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.14 | 1.03 | -0.52 | -0.5 | -0.5 | |
Capex to revenue | -0.29 | 0.32 | -0.16 | -0.18 | -0.18 | |
Capex to depreciation | -3.85 | 4.84 | -2.35 | -2.53 | -2.53 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Graham number | 0.69 | 0.3 | 0.42 | 0.88 | 1.24 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0.01 | 0.01 | |
Graham Net | -1.99 | -2.09 | -2 | -2.17 | -2.22 | |
Working capital | -829.25M | -742.31M | -800.25M | -812.97M | -856M | |
Tangible asset value | 955.53M | 955.54M | 955.54M | 1.01B | 1.01B | |
Net current asset value | -1.39B | -1.36B | -1.36B | -1.48B | -1.54B | |
Invested capital | 0.52 | 0.58 | 0.62 | 0.61 | 0.61 | |
Average receivables | 86.96M | 91.26M | 101.01M | 114M | 121.53M | |
Average payables | 45.66M | 27.72M | 9.79M | 30.94M | 52.09M | |
Average inventory | 0 | 0 | 53.84M | 53.84M | -29.38M | |
Days sales outstanding | 64.09 | 136.58 | 76.62 | 162.08 | 83.1 | |
Days payables outstanding | 33.36 | 21.05 | 6.99 | 106.15 | 34.5 | |
Days of inventory on hand | 0 | 0 | 76.91 | 0 | -38.92 | |
Receivables turnover | 1.4 | 0.66 | 1.17 | 0.56 | 1.08 | |
Payables turnover | 2.7 | 4.28 | 12.88 | 0.85 | 2.61 | |
Inventory turnover | 8266402.76B | 0 | 1.17 | 0 | -2.31 | |
ROE | 0.01 | 0 | 0 | 0.02 | 0.03 | |
Capex per share | -0.05 | 0.03 | -0.03 | -0.02 | -0.03 |
OCA.NZ Frequently Asked Questions
What is Oceania Healthcare Limited stock symbol ?
Oceania Healthcare Limited is a NZ stock and trading under the symbol OCA.NZ
What is Oceania Healthcare Limited stock quote today ?
Oceania Healthcare Limited stock price is $0.61 today.
Is Oceania Healthcare Limited stock public?
Yes, Oceania Healthcare Limited is a publicly traded company.